Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) FCF Margin (2016 - 2025)

Historic FCF Margin for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to 81.9%.

  • Biomerica's FCF Margin fell 335500.0% to 81.9% in Q4 2025 from the same period last year, while for Nov 2025 it was 66.51%, marking a year-over-year increase of 232300.0%. This contributed to the annual value of 72.32% for FY2025, which is 276200.0% up from last year.
  • As of Q4 2025, Biomerica's FCF Margin stood at 81.9%, which was down 335500.0% from 19.42% recorded in Q3 2025.
  • Biomerica's 5-year FCF Margin high stood at 30.6% for Q1 2022, and its period low was 177.09% during Q1 2024.
  • Its 5-year average for FCF Margin is 70.45%, with a median of 82.68% in 2025.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 1486700bps in 2021, then tumbled by -1864000bps in 2023.
  • Quarter analysis of 5 years shows Biomerica's FCF Margin stood at 28.62% in 2021, then plummeted by -392bps to 83.47% in 2022, then skyrocketed by 35bps to 54.12% in 2023, then increased by 11bps to 48.35% in 2024, then crashed by -69bps to 81.9% in 2025.
  • Its FCF Margin stands at 81.9% for Q4 2025, versus 19.42% for Q3 2025 and 88.25% for Q2 2025.